nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—GABRB2—autistic disorder	0.291	0.384	CbGaD
Etomidate—GABRA1—autistic disorder	0.285	0.377	CbGaD
Etomidate—CYP19A1—autistic disorder	0.181	0.24	CbGaD
Etomidate—SLC2A1—hindbrain—autistic disorder	0.00675	0.0966	CbGeAlD
Etomidate—SLC2A1—mouth—autistic disorder	0.00592	0.0847	CbGeAlD
Etomidate—SLC2A1—brainstem—autistic disorder	0.00387	0.0554	CbGeAlD
Etomidate—SLC2A1—eye—autistic disorder	0.00377	0.0539	CbGeAlD
Etomidate—SLC2A1—forebrain—autistic disorder	0.00373	0.0534	CbGeAlD
Etomidate—SLC2A1—telencephalon—autistic disorder	0.00343	0.0491	CbGeAlD
Etomidate—GABRB2—hindbrain—autistic disorder	0.00263	0.0377	CbGeAlD
Etomidate—SLC2A1—digestive system—autistic disorder	0.00262	0.0375	CbGeAlD
Etomidate—GABRA1—hindbrain—autistic disorder	0.00232	0.0333	CbGeAlD
Etomidate—SLC2A1—head—autistic disorder	0.00214	0.0306	CbGeAlD
Etomidate—SLC2A1—nervous system—autistic disorder	0.00203	0.029	CbGeAlD
Etomidate—SLC2A1—central nervous system—autistic disorder	0.00195	0.0279	CbGeAlD
Etomidate—SLC2A1—cerebellum—autistic disorder	0.00191	0.0273	CbGeAlD
Etomidate—SLC2A1—brain—autistic disorder	0.00155	0.0222	CbGeAlD
Etomidate—GABRB2—brainstem—autistic disorder	0.00151	0.0216	CbGeAlD
Etomidate—GABRB2—forebrain—autistic disorder	0.00146	0.0208	CbGeAlD
Etomidate—GABRG2—forebrain—autistic disorder	0.00146	0.0208	CbGeAlD
Etomidate—GABRB2—telencephalon—autistic disorder	0.00134	0.0192	CbGeAlD
Etomidate—GABRG2—telencephalon—autistic disorder	0.00134	0.0192	CbGeAlD
Etomidate—GABRA1—brainstem—autistic disorder	0.00133	0.0191	CbGeAlD
Etomidate—GABRA1—forebrain—autistic disorder	0.00129	0.0184	CbGeAlD
Etomidate—GABRA1—telencephalon—autistic disorder	0.00118	0.0169	CbGeAlD
Etomidate—CYP19A1—forebrain—autistic disorder	0.00118	0.0169	CbGeAlD
Etomidate—Pseudoephedrine—IL2—autistic disorder	0.00106	0.231	CrCbGaD
Etomidate—Pethidine—GRIN2A—autistic disorder	0.00099	0.216	CrCbGaD
Etomidate—GABRG2—head—autistic disorder	0.000834	0.0119	CbGeAlD
Etomidate—GABRB2—head—autistic disorder	0.000834	0.0119	CbGeAlD
Etomidate—GABRB2—nervous system—autistic disorder	0.00079	0.0113	CbGeAlD
Etomidate—GABRG2—nervous system—autistic disorder	0.00079	0.0113	CbGeAlD
Etomidate—GABRG2—central nervous system—autistic disorder	0.000761	0.0109	CbGeAlD
Etomidate—GABRB2—central nervous system—autistic disorder	0.000761	0.0109	CbGeAlD
Etomidate—GABRG2—cerebellum—autistic disorder	0.000744	0.0106	CbGeAlD
Etomidate—GABRB2—cerebellum—autistic disorder	0.000744	0.0106	CbGeAlD
Etomidate—GABRA1—head—autistic disorder	0.000736	0.0105	CbGeAlD
Etomidate—GABRA1—nervous system—autistic disorder	0.000698	0.00999	CbGeAlD
Etomidate—CYP19A1—head—autistic disorder	0.000676	0.00967	CbGeAlD
Etomidate—GABRA1—central nervous system—autistic disorder	0.000672	0.00962	CbGeAlD
Etomidate—GABRA1—cerebellum—autistic disorder	0.000657	0.0094	CbGeAlD
Etomidate—CYP19A1—nervous system—autistic disorder	0.000641	0.00917	CbGeAlD
Etomidate—CYP19A1—central nervous system—autistic disorder	0.000617	0.00883	CbGeAlD
Etomidate—GABRB2—brain—autistic disorder	0.000604	0.00865	CbGeAlD
Etomidate—GABRG2—brain—autistic disorder	0.000604	0.00865	CbGeAlD
Etomidate—Pethidine—OPRM1—autistic disorder	0.00054	0.118	CrCbGaD
Etomidate—GABRA1—brain—autistic disorder	0.000533	0.00763	CbGeAlD
Etomidate—CYP19A1—brain—autistic disorder	0.00049	0.00701	CbGeAlD
Etomidate—Pseudoephedrine—MAOA—autistic disorder	0.000445	0.0972	CrCbGaD
Etomidate—Ephedrine—ADRB2—autistic disorder	0.000417	0.0911	CrCbGaD
Etomidate—Pseudoephedrine—ADRB2—autistic disorder	0.000316	0.069	CrCbGaD
Etomidate—Pethidine—SLC6A4—autistic disorder	0.000297	0.0649	CrCbGaD
Etomidate—Pseudoephedrine—SLC6A4—autistic disorder	0.000287	0.0627	CrCbGaD
Etomidate—Fenoprofen—PTGS2—autistic disorder	0.000233	0.0508	CrCbGaD
Etomidate—ADRA2B—GPCR ligand binding—CALCA—autistic disorder	2.96e-05	0.000175	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PRKCB—autistic disorder	2.95e-05	0.000175	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GRM8—autistic disorder	2.95e-05	0.000174	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—PRKCB—autistic disorder	2.93e-05	0.000173	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR1D—autistic disorder	2.88e-05	0.00017	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.87e-05	0.00017	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	2.86e-05	0.000169	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.86e-05	0.000169	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—APOE—autistic disorder	2.83e-05	0.000168	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CG—autistic disorder	2.82e-05	0.000167	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—autistic disorder	2.81e-05	0.000166	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TPH2—autistic disorder	2.8e-05	0.000166	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—EGF—autistic disorder	2.79e-05	0.000165	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PDE4A—autistic disorder	2.77e-05	0.000164	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ASMT—autistic disorder	2.76e-05	0.000164	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTM5—autistic disorder	2.76e-05	0.000164	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—DPYD—autistic disorder	2.76e-05	0.000163	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—TF—autistic disorder	2.72e-05	0.000161	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—DHFR—autistic disorder	2.7e-05	0.00016	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL5—autistic disorder	2.68e-05	0.000159	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GRM8—autistic disorder	2.68e-05	0.000158	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SERPINE1—autistic disorder	2.65e-05	0.000157	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	2.62e-05	0.000155	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC25A12—autistic disorder	2.6e-05	0.000154	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AVPR1A—autistic disorder	2.59e-05	0.000154	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—WNT2—autistic disorder	2.59e-05	0.000153	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.59e-05	0.000153	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IGF1—autistic disorder	2.58e-05	0.000153	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CACNA1C—autistic disorder	2.56e-05	0.000152	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—PRKCB—autistic disorder	2.56e-05	0.000151	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CG—autistic disorder	2.56e-05	0.000151	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—POMC—autistic disorder	2.56e-05	0.000151	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ITGA4—autistic disorder	2.56e-05	0.000151	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	2.55e-05	0.000151	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC19A1—autistic disorder	2.53e-05	0.00015	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PDE4A—autistic disorder	2.52e-05	0.000149	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—VIP—autistic disorder	2.51e-05	0.000148	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GRM5—autistic disorder	2.51e-05	0.000148	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—ADRB2—autistic disorder	2.48e-05	0.000147	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.46e-05	0.000146	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—autistic disorder	2.45e-05	0.000145	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—POMC—autistic disorder	2.43e-05	0.000144	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—OXTR—autistic disorder	2.43e-05	0.000144	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—SCT—autistic disorder	2.4e-05	0.000142	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—AVP—autistic disorder	2.36e-05	0.00014	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AVPR1A—autistic disorder	2.36e-05	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NRP2—autistic disorder	2.34e-05	0.000139	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—DHFR—autistic disorder	2.33e-05	0.000138	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PLAUR—autistic disorder	2.33e-05	0.000138	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—AVP—autistic disorder	2.33e-05	0.000138	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—autistic disorder	2.32e-05	0.000137	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	2.3e-05	0.000136	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADM—autistic disorder	2.29e-05	0.000136	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GABBR1—autistic disorder	2.29e-05	0.000136	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	2.29e-05	0.000135	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—autistic disorder	2.28e-05	0.000135	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.28e-05	0.000135	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—VIP—autistic disorder	2.28e-05	0.000135	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GRM5—autistic disorder	2.28e-05	0.000135	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ADSL—autistic disorder	2.25e-05	0.000133	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR5A—autistic disorder	2.24e-05	0.000133	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PDE4B—autistic disorder	2.23e-05	0.000132	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—XDH—autistic disorder	2.21e-05	0.000131	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—OXTR—autistic disorder	2.2e-05	0.00013	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SCT—autistic disorder	2.18e-05	0.000129	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—STX1A—autistic disorder	2.17e-05	0.000128	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NPAS2—autistic disorder	2.17e-05	0.000128	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—OPRM1—autistic disorder	2.16e-05	0.000128	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—AVP—autistic disorder	2.16e-05	0.000128	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—MAPK1—autistic disorder	2.15e-05	0.000127	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP19A1—autistic disorder	2.12e-05	0.000125	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	2.1e-05	0.000124	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TCN2—autistic disorder	2.09e-05	0.000124	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADM—autistic disorder	2.08e-05	0.000123	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GABBR1—autistic disorder	2.08e-05	0.000123	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF2—autistic disorder	2.07e-05	0.000123	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	2.03e-05	0.00012	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PDE4B—autistic disorder	2.03e-05	0.00012	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTEN—autistic disorder	2.02e-05	0.00012	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ADA—autistic disorder	2e-05	0.000118	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.99e-05	0.000118	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2—autistic disorder	1.99e-05	0.000118	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	1.97e-05	0.000117	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—COMT—autistic disorder	1.97e-05	0.000117	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.97e-05	0.000117	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.96e-05	0.000116	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—OPRM1—autistic disorder	1.96e-05	0.000116	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTP1—autistic disorder	1.96e-05	0.000116	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PLA2G4A—autistic disorder	1.96e-05	0.000116	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MAOA—autistic disorder	1.96e-05	0.000116	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—autistic disorder	1.94e-05	0.000115	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR2A—autistic disorder	1.94e-05	0.000115	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR1B—autistic disorder	1.92e-05	0.000114	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—OXT—autistic disorder	1.92e-05	0.000114	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GABBR2—autistic disorder	1.91e-05	0.000113	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CAT—autistic disorder	1.91e-05	0.000113	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	1.89e-05	0.000112	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—AVP—autistic disorder	1.89e-05	0.000112	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ITGB3—autistic disorder	1.86e-05	0.00011	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.84e-05	0.000109	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP19A1—autistic disorder	1.83e-05	0.000108	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—RORA—autistic disorder	1.82e-05	0.000108	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PLA2G4A—autistic disorder	1.8e-05	0.000107	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTM1—autistic disorder	1.8e-05	0.000107	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DRD1—autistic disorder	1.79e-05	0.000106	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR1B—autistic disorder	1.74e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—OXT—autistic disorder	1.74e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DRD3—autistic disorder	1.73e-05	0.000102	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—HRAS—autistic disorder	1.73e-05	0.000102	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GPX1—autistic disorder	1.72e-05	0.000102	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.72e-05	0.000102	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.71e-05	0.000101	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MAOB—autistic disorder	1.71e-05	0.000101	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR1D—autistic disorder	1.7e-05	0.000101	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—COMT—autistic disorder	1.7e-05	0.0001	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTEN—autistic disorder	1.69e-05	0.0001	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL5—autistic disorder	1.69e-05	0.0001	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTP1—autistic disorder	1.69e-05	0.0001	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MAOA—autistic disorder	1.68e-05	9.97e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CALCA—autistic disorder	1.67e-05	9.9e-05	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—MAPK1—autistic disorder	1.65e-05	9.76e-05	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MAPK1—autistic disorder	1.64e-05	9.73e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CAT—autistic disorder	1.64e-05	9.73e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRLR—autistic disorder	1.64e-05	9.69e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.62e-05	9.62e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DRD1—autistic disorder	1.62e-05	9.6e-05	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6—autistic disorder	1.61e-05	9.55e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MTHFR—autistic disorder	1.59e-05	9.42e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TPH2—autistic disorder	1.59e-05	9.4e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRM8—autistic disorder	1.58e-05	9.36e-05	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—HRAS—autistic disorder	1.58e-05	9.36e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DRD3—autistic disorder	1.57e-05	9.3e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—DPYD—autistic disorder	1.56e-05	9.24e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PLA2G4A—autistic disorder	1.55e-05	9.19e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTM1—autistic disorder	1.55e-05	9.19e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—POMC—autistic disorder	1.55e-05	9.16e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL5—autistic disorder	1.54e-05	9.1e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—WNT2—autistic disorder	1.53e-05	9.06e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PRKCB—autistic disorder	1.52e-05	9e-05	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—MAPK1—autistic disorder	1.52e-05	8.99e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CALCA—autistic disorder	1.52e-05	8.99e-05	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—MAPK1—autistic disorder	1.51e-05	8.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GHR—autistic disorder	1.51e-05	8.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS2—autistic disorder	1.5e-05	8.89e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDE4A—autistic disorder	1.49e-05	8.8e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GPX1—autistic disorder	1.49e-05	8.8e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOE—autistic disorder	1.48e-05	8.77e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.47e-05	8.68e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CG—autistic disorder	1.45e-05	8.61e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CACNA1C—autistic disorder	1.45e-05	8.59e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EGF—autistic disorder	1.44e-05	8.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADRB2—autistic disorder	1.4e-05	8.29e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.4e-05	8.26e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AVPR1A—autistic disorder	1.39e-05	8.24e-05	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—HRAS—autistic disorder	1.38e-05	8.18e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MTHFR—autistic disorder	1.37e-05	8.12e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRM5—autistic disorder	1.34e-05	7.96e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VIP—autistic disorder	1.34e-05	7.96e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CG—autistic disorder	1.34e-05	7.92e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF1—autistic disorder	1.33e-05	7.88e-05	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—HRAS—autistic disorder	1.32e-05	7.84e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—DHFR—autistic disorder	1.32e-05	7.82e-05	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HRAS—autistic disorder	1.32e-05	7.81e-05	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—MAPK1—autistic disorder	1.32e-05	7.8e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AVP—autistic disorder	1.32e-05	7.79e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—OXTR—autistic disorder	1.3e-05	7.71e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SCT—autistic disorder	1.29e-05	7.63e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOE—autistic disorder	1.28e-05	7.56e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—POMC—autistic disorder	1.27e-05	7.54e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADRB2—autistic disorder	1.27e-05	7.53e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SERPINE1—autistic disorder	1.26e-05	7.48e-05	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6—autistic disorder	1.26e-05	7.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADM—autistic disorder	1.23e-05	7.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GABBR1—autistic disorder	1.23e-05	7.28e-05	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—HRAS—autistic disorder	1.21e-05	7.17e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EIF4E—autistic disorder	1.21e-05	7.15e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDE4B—autistic disorder	1.2e-05	7.09e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AVP—autistic disorder	1.2e-05	7.08e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—OPRM1—autistic disorder	1.16e-05	6.87e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CG—autistic disorder	1.15e-05	6.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PLA2G4A—autistic disorder	1.12e-05	6.65e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.11e-05	6.59e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—POMC—autistic disorder	1.1e-05	6.49e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2A—autistic disorder	1.1e-05	6.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GZMB—autistic disorder	1.06e-05	6.28e-05	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—HRAS—autistic disorder	1.06e-05	6.27e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—OXT—autistic disorder	1.03e-05	6.1e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR1B—autistic disorder	1.03e-05	6.1e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL2—autistic disorder	1.02e-05	6.06e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—autistic disorder	1.02e-05	6.01e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2A—autistic disorder	9.95e-06	5.89e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	9.71e-06	5.75e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—COMT—autistic disorder	9.62e-06	5.69e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PRKCB—autistic disorder	9.6e-06	5.68e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TSC1—autistic disorder	9.58e-06	5.67e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD1—autistic disorder	9.58e-06	5.67e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTP1—autistic disorder	9.57e-06	5.67e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MAOA—autistic disorder	9.55e-06	5.65e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTRK2—autistic disorder	9.32e-06	5.52e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CAT—autistic disorder	9.31e-06	5.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD3—autistic disorder	9.28e-06	5.49e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CG—autistic disorder	9.19e-06	5.44e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL5—autistic disorder	9.08e-06	5.38e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CALCA—autistic disorder	8.97e-06	5.31e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTEN—autistic disorder	8.85e-06	5.24e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTM1—autistic disorder	8.8e-06	5.21e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLA2G4A—autistic disorder	8.8e-06	5.21e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—autistic disorder	8.75e-06	5.18e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—POMC—autistic disorder	8.75e-06	5.18e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCB—autistic disorder	8.72e-06	5.16e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GPX1—autistic disorder	8.42e-06	4.99e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CG—autistic disorder	8.35e-06	4.94e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—POMC—autistic disorder	7.94e-06	4.7e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRL—autistic disorder	7.92e-06	4.69e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MAPK1—autistic disorder	7.83e-06	4.63e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MTHFR—autistic disorder	7.77e-06	4.6e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTEN—autistic disorder	7.63e-06	4.52e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRB2—autistic disorder	7.52e-06	4.45e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOE—autistic disorder	7.24e-06	4.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AVP—autistic disorder	7.06e-06	4.18e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF2—autistic disorder	7.03e-06	4.16e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLA2G4A—autistic disorder	6.64e-06	3.93e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CG—autistic disorder	6.53e-06	3.87e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2—autistic disorder	6.47e-06	3.83e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MEF2C—autistic disorder	6.46e-06	3.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ITGB3—autistic disorder	6.29e-06	3.73e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HRAS—autistic disorder	6.28e-06	3.72e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—POMC—autistic disorder	6.22e-06	3.68e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2A—autistic disorder	5.88e-06	3.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2—autistic disorder	5.87e-06	3.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TSC2—autistic disorder	5.58e-06	3.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOE—autistic disorder	5.46e-06	3.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LEP—autistic disorder	5.46e-06	3.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCB—autistic disorder	5.15e-06	3.05e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—autistic disorder	4.96e-06	2.94e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APC—autistic disorder	4.93e-06	2.92e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CG—autistic disorder	4.93e-06	2.92e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGF—autistic disorder	4.87e-06	2.88e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—POMC—autistic disorder	4.69e-06	2.78e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1—autistic disorder	4.51e-06	2.67e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MAPK1—autistic disorder	4.49e-06	2.66e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTEN—autistic disorder	4.32e-06	2.56e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SERPINE1—autistic disorder	4.29e-06	2.54e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HRAS—autistic disorder	3.61e-06	2.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2—autistic disorder	3.47e-06	2.05e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—autistic disorder	3.45e-06	2.04e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTEN—autistic disorder	3.26e-06	1.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK1—autistic disorder	2.65e-06	1.57e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HRAS—autistic disorder	2.13e-06	1.26e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—autistic disorder	2.04e-06	1.21e-05	CbGpPWpGaD
